An observational study in Rotator Cuff Injuries, sponsored by Istanbul Medeniyet University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-04.
Sponsored by Istanbul Medeniyet University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 85 studies in Rotator Cuff Injuries with a site in Turkey — 19 open to participants now, 22 under way, none of them phase 3. Rotator Cuff Injuries · Turkey.
Among the 85 studies in Rotator Cuff Injuries with a site in Turkey, this one is the 5th largest by planned enrollment of the 22 observational ones that give a count, is one of 13 that started in 2026, is one of 22 observational ones, reaches primary completion later than 15 of the 21 other live ones, and was the 84th registered.
632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.
Browse Rotator Cuff Injuries studies →19 of the 85 studies in Rotator Cuff Injuries with a site in Turkey are open now. Recruiting first, the newest first:
Firat University · Sites in Turkey
Ages 18–65
Ahi Evran University Education and Research Hospital · Sites in Turkey
Ages 40–60
Istanbul Nisantasi University · Sites in Turkey
Ages 18–75
Balikesir Ataturk City Hospital · Sites in Turkey
Ages 18+
Kirsehir Ahi Evran Universitesi · Sites in Turkey
Ages 18–65
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
85 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 13 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is above the median of 71 across 146 observational studies indexed under Rotator Cuff Injuries.
Median enrollment 44 across the 63 interventional studies, 50 across the 22 observational. Of the 58 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 85 has an industry lead sponsor. The 10 most frequent:
Istanbul Medeniyet University is the lead sponsor of 193 studies on the registry; 17 are open to participants now.
Istanbul Medeniyet University has 3 studies filed under Rotator Cuff Injuries — fewer than ten, so there is no comparison to draw.
3 of the studies in Rotator Cuff Injuries with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07377292Ahi Evran University Education and Research HospitalEffectiveness of Core Stabilization Exercises in Rotator Cuff Injuries | 2026-12-25 |
| NCT07853950Ataturk UniversityFibrin Clot Augmentation in Arthroscopic Rotator Cuff Repair | 2027-02-28 |
| NCT07428070Istanbul Nisantasi UniversityContextually Enhanced Exercise Programs for Rotator Cuff-Related Shoulder Pain | 2027-05-06 |
Add all 3 to your calendar (.ics) → With an account.
Among the 85 studies in Rotator Cuff Injuries with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The rotator cuff consists of the supraspinatus, infraspinatus, teres minor, and subscapularis muscles and their tendons, which surround and stabilize the shoulder joint. Rotator cuff-related disorders may cause pain, particularly during arm elevation and external rotation, and may limit shoulder movement and daily function.
Shoulder function depends not only on the muscles surrounding the shoulder but also on the coordinated transfer of force through the trunk and extremities, known as the kinetic chain. Impairments in trunk muscle function, core stability, proprioception, and balance may therefore negatively affect shoulder mechanics.
This study aims to investigate the relationships between latissimus dorsi and abdominal muscle thickness, trunk proprioception, and postural stability in individuals with rotator cuff pathology. The study will also examine whether these measurements differ between individuals with rotator cuff pathology and healthy participants.
The rotator cuff consists of the supraspinatus, infraspinatus, teres minor, and subscapularis muscles and their tendons and surrounds the shoulder joint. Rotator cuff syndrome includes various conditions affecting the rotator cuff, such as subacromial impingement syndrome, bursitis, tendinitis, and partial- or full-thickness rotator cuff tears. Rotator cuff-related shoulder pain generally refers to a painful clinical condition that occurs during shoulder elevation and external rotation and is accompanied by limitations in shoulder movement and function. Its etiology is multifactorial. The combination of extrinsic mechanical compression, such as narrowing of the subacromial space, and tendon overuse, such as repetitive overhead activities, has been identified as one of the main mechanisms underlying rotator cuff pathology. Diagnosis is based on medical history, physical examination, and imaging when necessary.
Sequential physiological muscle activations in the upper and lower extremities create an integrated biomechanical task. This sequential organization is referred to as the kinetic chain. During activities predominantly involving the upper extremity, energy is generated and transferred from the proximal to the distal segments. A disruption within the kinetic chain may result in dysfunctional biomechanical outcomes and contribute to the development of pain and injury. Impairments in the proximal components of the kinetic chain may negatively affect shoulder function. Therefore, in patients with shoulder disorders, all components that may impair kinetic chain function should be evaluated.
Core stability is defined as the ability to control the position and movement of the trunk over the pelvis in order to enable optimal force generation and the transfer and control of force and movement to the distal segment during activity. Core muscle activity provides both stability and movement. This mechanism enables proximal stability for distal mobility, the sequential transfer of force from proximal to distal segments, and the generation of intersegmental moments that move and protect the distal joints. The core region is important for providing local strength and balance. It is also positioned at the center of almost all kinetic chains involved in sporting activities. Therefore, adequate core muscle strength facilitates effective control of balance and movement and supports the optimal functioning of kinetic chains associated with both upper- and lower-extremity activities.
The sensorimotor system includes all sensory and motor components involved in maintaining joint stability, together with their central integration and processing mechanisms. This system consists of several components, including proprioception, joint position sense, kinesthesia, force sense, and neuromuscular control. When a shoulder injury occurs, not only mechanical structures such as the joint capsule and glenoid labrum may be affected, but the sensorimotor system may also be impaired. Shoulder injuries may be accompanied by deficits in both proprioception and neuromuscular control, which may consequently result in balance impairments.
Some studies have suggested that pain may also contribute to balance impairment. A possible explanation is that pain-processing mechanisms, the neuronal networks responsible for balance control, and pain-related muscle inhibition partly involve shared pathways within the central nervous system. A recent study conducted in Türkiye that investigated balance in patients with shoulder pain reported a significant difference in balance between the patient and control groups. The study also found that balance impairment was positively associated with pain severity.
This study aims to investigate the relationships between latissimus dorsi and abdominal muscle thickness, trunk proprioception, and postural stability in individuals with rotator cuff pathology. The study will also examine whether these measurements differ between individuals with rotator cuff pathology and healthy participants.
Study participants will be selected from adults evaluated at the Physical Medicine and Rehabilitation outpatient clinic of Göztepe Prof. Dr. Süleyman Yalçın City Hospital. The patient group will include right-hand-dominant adults with unilateral shoulder pain lasting at least 3 months and a diagnosis of rotator cuff pathology. The control group will include right-hand-dominant healthy adults without shoulder pain who meet the study eligibility criteria.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Rotator Cuff Pathology Group
Healthy Control Group
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adults with unilateral shoulder pain lasting at least 3 months and magnetic resonance imaging-confirmed rotator cuff pathology.
Healthy adults without shoulder pain or a known history of rotator cuff pathology.
Abdominal Muscle Thicknesses
The thicknesses of the rectus abdominis, external oblique, internal oblique, and transversus abdominis muscles will be measured separately in millimeters using diagnostic ultrasonography. Participants will be assessed in the supine position with a pillow placed under the knees. Lateral abdominal muscle measurements will be performed at the midpoint of a line drawn between the anterior superior iliac spine and the inferior border of the lowest rib at the midaxillary line. Rectus abdominis thickness will be measured immediately above the umbilicus at the thickest visible region of the muscle. Minimal transducer pressure will be applied to avoid compression of the muscle tissue. Each measurement will be repeated three times, and the mean of the three measurements will be used in the analysis.
Time frame: During the single assessment visit at enrollment (Day 1)
Latissimus Dorsi Muscle Thickness
Latissimus dorsi muscle thickness will be measured with participants in the prone position, with both upper extremities relaxed and positioned alongside the body and the trunk maintained in a neutral position. The measurement site will be identified at the level of the 10th rib along a line drawn between the midpoint of the axilla and a point located 2 cm medial to the posterior superior iliac spine. The ultrasound transducer will be positioned perpendicular to the 10th rib at this level, and latissimus dorsi muscle thickness will be measured at this site. Minimal transducer pressure will be applied to avoid compression of the muscle tissue. Each measurement will be repeated three times, and the mean of the three measurements will be used in the analysis.
Time frame: During the single assessment visit at enrollment (Day 1)
Static Postural Stability
Static postural stability will be assessed using a pedobarographic platform. Participants will stand on the platform under standardized testing conditions, and postural sway parameters recorded by the system will be used to evaluate static balance. Higher postural sway values indicate poorer static postural stability.
Time frame: During the single assessment visit at enrollment (Day 1)
Trunk Proprioception
Trunk proprioception will be assessed using a digital inclinometer and the active repositioning method. Participants will sit at the edge of a bed with the feet supported, hips and knees flexed to 90°, and the pelvis stabilized. The inclinometer will be positioned over the T4 spinous process. After three practice trials, participants will perform 30° trunk flexion with their eyes open and maintain the target position for 5 seconds. They will then return to the target position with their eyes closed. The absolute difference between the target and reproduced angles will be recorded in degrees. Three measurements will be performed, and the mean repositioning error will be used in the analysis. Higher values indicate poorer trunk proprioception.
Time frame: During the single assessment visit at enrollment (Day 1)
Timed Up and Go Test (TUG)
Functional mobility will be assessed using the Timed Up and Go Test. Participants will be instructed to rise from a chair, walk a distance of 3 meters at a comfortable pace, turn, walk back to the chair, and sit down. The time required to complete the test will be recorded in seconds. A longer completion time indicates poorer functional mobility.
Time frame: During the single assessment visit at enrollment (Day 1)
Walking Speed
Walking speed will be assessed during a standardized walking test and calculated in meters per second by dividing the walking distance by the time required to complete the test. A higher value indicates a faster walking speed.
Time frame: During the single assessment visit at enrollment (Day 1)
Abdominal Flexion and Lateral Flexion Muscle Strength
Abdominal flexion and lateral flexion muscle strength will be assessed using standardized manual muscle testing procedures. Muscle strength will be graded on an ordinal scale from 0 to 5, where 0 indicates no visible or palpable muscle contraction and 5 indicates the ability to complete the movement against full manual resistance.
Time frame: During the single assessment visit at enrollment (Day 1)
Flexor Endurance Test
Trunk flexor endurance will be assessed using the flexor endurance test. Participants will sit with the trunk supported at approximately 60°, the hips and knees flexed to 90°, and the arms crossed over the chest. The support will then be moved approximately 10 cm backward, and participants will be instructed to maintain the position for as long as possible. The test will end when the trunk falls below the 60° position. The duration will be recorded in seconds, with shorter times indicating lower trunk flexor endurance.
Time frame: During the single assessment visit at enrollment (Day 1)
Plan to share: No — Individual participant data will not be shared because participant consent was obtained for use of the data within the scope of this study, and no data-sharing plan was established in the study protocol.
No publications or documents are linked to this record.
Start is estimated for Aug 2026; primary completion for Oct 2026, 2 months later.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Medeniyet University →